Towards safer ERCP: Selection, experience and prophylaxis

Revista Espanola de Enfermedades Digestivas

Volumn 96, Issue 3, 2004, Pages 155-162

  Rodriguez Munoz S ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMYLASE; ANTIBIOTIC AGENT; CONTRAST MEDIUM; CORTICOSTEROID; CYTOKINE; GLYCERYL TRINITRATE; HEPARIN; INTERLEUKIN 10; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOSTATIN;

ABDOMINAL PAIN; AMYLASE BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; BILIARY TRACT SURGERY; BLEEDING; BLOOD TRANSFUSION; CHOLANGITIS; CHOLECYSTECTOMY; CHOLECYSTITIS; COMMON BILE DUCT STONE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; MEDICAL DECISION MAKING; MORTALITY; PANCREAS DUCT LIGATION; PANCREATITIS; PATIENT SELECTION; PERFORATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; HUMANS; PANCREATITIS; PATIENT SELECTION; SAFETY;

EID: 1942519856     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of Vater: a preliminary report. Ann Surg 1968; 167: 752-6.
2. Mallery JS, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, et al. Coplications of ERCP. Gastrointest Endosc 2003; 57: 633-8.
3. Petersen BT. ERCP outcomes: defining the operators, experience, and enviroments. Gastrointest Endosc 2002: 55: 953-8.
4. Arenson N, Flamm CR, Bohn RL, Mark DH, Speroff T. Evidence-based assessment. Patient procedure, or operator factors associated with ERCP complications. Gastrointest Endosc 2002; 56: s294-s301.
5. García-Cano Lizcano J, González Martín JA, Morillas Ariño J, Pérez Sola A. Complicaciones de la colangio-pancreatografía retrógrada endoscópica. Estudio en una unidad pequeña de CPRE. Rev Esp Enferm Dig 2004; 96 (3): 163-73.
6. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PP, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliarysphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-24.
7. Hogan W. Stenting the Pancreas: Is this the solution to post-ERCP pancreatitis? Gastroenterology 1998; 115: 1591-4.
8. Andriulli A, Leandro G, Niro G, Manglia A, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endsoc 2000; 51: 1-7.
9. Moretó M, Zaballa M, Casado I, Merino O, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 2003; 57: 1-7.
10. Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, et al. Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002; 55: 476-83.
11. Devière J, Le Moine O, Van Lathem JL, Eisendrath P, et al. Interleukin °10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505.
12. Murray B, Carter R, Imrie C, Evans S, O'Suillleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003; 124: 1786-91.
13. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman, ME, Dorsher PT, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335: 909-18.
14. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48: 1-10.
15. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96: 417-23.
16. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Gastrointest Endosc 2001; 54: 425-34.
17. Trap R, Adamsen S, Hart-Hansen O, Henricksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999; 31: 125-30.